60 Degrees Pharmaceutical...

NASDAQ: SXTP · Real-Time Price · USD
1.30
-0.01 (-0.76%)
At close: Aug 15, 2025, 12:15 PM

60 Degrees Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
681.35K 253.57K 223.21K 1.16M
Cost of Revenue
384.76K 474.55K 432.37K 850.74K
Gross Profit
222.81K -220.98K -209.16K 309.6K
Operating Income
-9.71M -5.15M -1.75M -1.12M
Interest Income
n/a n/a n/a n/a
Pretax Income
-7.96M -3.81M -6.18M -4.26M
Net Income
-7.95M -3.77M -6.18M -4.25M
Selling & General & Admin
5.02M 4.24M 1.3M 1.12M
Research & Development
4.99M 691.77K 525.56K 5.51M
Other Expenses
n/a n/a -288K -5.19M
Operating Expenses
10.01M 4.93M 1.54M 1.43M
Interest Expense
7.91K 2.29M 3.99M 3.17M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
10.4M 5.41M 1.97M 2.28M
Income Tax Expense
250.00 250.00 500.00 1K
Shares Outstanding (Basic)
454.58K 3.96M 5.78M 5.78M
Shares Outstanding (Diluted)
454.58K 3.96M 5.78M 5.78M
EPS (Basic)
-18.55 -0.95 -1.07 -0.74
EPS (Diluted)
-18.55 -0.95 -1.07 -0.74
EBITDA
-7.88M -1.43M -2.11M -1.01M
EBIT
-7.95M -1.53M -2.19M -1.09M
Depreciation & Amortization
63.74K 100.37K 78.79K 71.78K